Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era.
about
Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamideeIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.Estrogenic side effects of androgen deprivation therapy.An update on TroVax for the treatment of progressive castration-resistant prostate cancerCost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer.Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer.Hormone-refractory prostate cancer: what have we learned?Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.Individualized strategy for dosing luteinizing hormone-releasing hormone agonists for androgen-independent prostate cancer: identification of outcomes and costs.Update in palliative management of hormone refractory cancer of prostate.Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer.Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians.Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy.May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?Comorbidity and competing risks for mortality in men with prostate cancer.Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis.A Study of the Anti-Cancer Effects of the Hexane Fraction of the Methanol Extract of Forsythiae Fructus.Association of stress management skills and perceived stress with physical and emotional well-being among advanced prostrate cancer survivors following androgen deprivation treatment.
P2860
Q24669875-5874FE15-5AC8-4565-9E23-0E9A2C2445DDQ34069836-C698AE1F-A1B7-4DFD-B8EF-DB4E980917E4Q34743239-B23FD519-C249-47FC-A0FB-D125ACACA230Q35050205-B1BA5E09-0D88-4E58-AB83-73632F7BAE30Q35947797-7EEAE7F8-F721-4588-BE8F-B7CBEFC399BBQ36015058-3B63AA57-1563-4A24-9947-95A72C8A6230Q36861789-9337D0DF-09CA-41A7-9E5D-9B6E4553161DQ37028339-F94E77BA-9E89-4B05-A5A8-86EBF03F4F49Q37478907-7E45A0E4-62E1-4AF9-B876-34D10B6A39EFQ37579073-56C70F71-8853-4F3E-98F2-D4C6A9FE4B86Q37996104-8FBCE180-0214-4616-BF89-49483414E789Q39283679-10C5E635-2850-4386-87B5-9DBFC74B01A8Q42256057-B71F81B8-4626-4190-847D-F64581642083Q43477210-B0E0D100-B2B8-4270-86E9-24EAC3BA1E45Q45064053-95B70E96-6CFF-48E9-93D8-48860C811512Q46956969-F5DCE1EC-A249-49A4-87BD-C84FA7076385Q47135229-114B8DA5-C0B7-48D6-96C0-AA90625CCBCAQ48423110-C9E68B7D-E859-4D0E-AC88-63B68F7E9284
P2860
Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Survival of patients with horm ...... prostate specific antigen era.
@en
Survival of patients with horm ...... prostate specific antigen era.
@nl
type
label
Survival of patients with horm ...... prostate specific antigen era.
@en
Survival of patients with horm ...... prostate specific antigen era.
@nl
prefLabel
Survival of patients with horm ...... prostate specific antigen era.
@en
Survival of patients with horm ...... prostate specific antigen era.
@nl
P1476
Survival of patients with horm ...... prostate specific antigen era.
@en
P2093
Martin I Resnick
Michael G Oefelein
P304
P356
10.1097/01.JU.0000118294.88852.CD
P407
P577
2004-04-01T00:00:00Z